Literature DB >> 32430846

The enzymology of the human prostanoid pathway.

Roger Gregory Biringer1.   

Abstract

Prostanoids are short-lived autocrine and paracrine signaling molecules involved in a wide range of biological functions. They have been shown to be intimately involved in many different disease states when their regulation becomes dysfunctional. In order to fully understand the progression of any disease state or the biological functions of the well state, a complete evaluation of the genomics, proteomics, and metabolomics of the system is necessary. This review is focused on the enzymology for the enzymes involved in the synthesis of the prostanoids (prostaglandins, prostacyclins and thromboxanes). In particular, the isolation and purification of the enzymes, their enzymatic parameters and catalytic mechanisms are presented.

Entities:  

Keywords:  Enzymology; Kinetics; Prostacyclin; Prostaglandin; Prostanoid; Thromboxane

Mesh:

Substances:

Year:  2020        PMID: 32430846     DOI: 10.1007/s11033-020-05526-z

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  101 in total

1.  In vitro assays for cyclooxygenase activity and inhibitor characterization.

Authors:  Mark C Walker; James K Gierse
Journal:  Methods Mol Biol       Date:  2010

Review 2.  Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2.

Authors:  W L Smith; R M Garavito; D L DeWitt
Journal:  J Biol Chem       Date:  1996-12-27       Impact factor: 5.157

3.  A mechanistic study of self-inactivation of the peroxidase activity in prostaglandin H synthase-1.

Authors:  G Wu; C Wei; R J Kulmacz; Y Osawa; A L Tsai
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

4.  Measurement of cyclooxygenase inhibition using liquid chromatography-tandem mass spectrometry.

Authors:  Hongmei Cao; Rui Yu; Yi Tao; Dejan Nikolic; Richard B van Breemen
Journal:  J Pharm Biomed Anal       Date:  2010-08-13       Impact factor: 3.935

5.  Recent reports about enzymes related to the synthesis of prostaglandin (PG) F(2) (PGF(2α) and 9α, 11β-PGF(2)).

Authors:  Kikuko Watanabe
Journal:  J Biochem       Date:  2011-09-16       Impact factor: 3.387

6.  Characterization of the glycosylation sites in cyclooxygenase-2 using mass spectrometry.

Authors:  J F Nemeth; G P Hochgesang; L J Marnett; R M Caprioli; G P Hochensang
Journal:  Biochemistry       Date:  2001-03-13       Impact factor: 3.162

7.  Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs.

Authors:  O Laneuville; D K Breuer; D L Dewitt; T Hla; C D Funk; W L Smith
Journal:  J Pharmacol Exp Ther       Date:  1994-11       Impact factor: 4.030

8.  An ELISA method to measure inhibition of the COX enzymes.

Authors:  Muriel Cuendet; Andrew D Mesecar; David L DeWitt; John M Pezzuto
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

9.  A Revised Mechanism for Human Cyclooxygenase-2.

Authors:  Yi Liu; Justine P Roth
Journal:  J Biol Chem       Date:  2015-11-12       Impact factor: 5.157

Review 10.  Prostaglandin H synthase: resolved and unresolved mechanistic issues.

Authors:  Ah-Lim Tsai; Richard J Kulmacz
Journal:  Arch Biochem Biophys       Date:  2009-09-01       Impact factor: 4.013

View more
  4 in total

Review 1.  Endocannabinoid signaling pathways: beyond CB1R and CB2R.

Authors:  Roger Gregory Biringer
Journal:  J Cell Commun Signal       Date:  2021-05-12       Impact factor: 5.782

Review 2.  The rise and fall of anandamide: processes that control synthesis, degradation, and storage.

Authors:  Roger Gregory Biringer
Journal:  Mol Cell Biochem       Date:  2021-03-13       Impact factor: 3.396

3.  Anti-Inflammatory and Antioxidant Capacity of a Fruit and Vegetable-Based Nutraceutical Measured by Urinary Oxylipin Concentration in a Healthy Population: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Authors:  Raúl Arcusa; Juan Ángel Carrillo; Begoña Cerdá; Thierry Durand; Ángel Gil-Izquierdo; Sonia Medina; Jean-Marie Galano; Débora Villaño Valencia; Javier Marhuenda; Pilar Zafrilla
Journal:  Antioxidants (Basel)       Date:  2022-07-08

Review 4.  Prostanoid Metabolites as Biomarkers in Human Disease.

Authors:  Helena Idborg; Sven-Christian Pawelzik
Journal:  Metabolites       Date:  2022-08-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.